Free Subscription to CFO Magazine

You are here: Home : Chart

2002 Working Capital Survey - Chart 29
Medical & Biological Technology
CFO Staff, CFO Magazine

MEDICAL & BIOLOGICAL TECHNOLOGY

Company Name Sales ($ Mill.) DWC DWC Change Over Last Year DWC 3 Year Ave. DPO DPO Change Over Last Year DPO 3 Year Ave. Inven- tory Turns Inven- tory Turns Change Over Last Year Inven- tory Turns 3 Year Ave. DSO DSO Change Over Last Year DSO 3 Year Ave. CCE CCE 3 Year Ave.

AMGEN INC.

$4,016

65

10

61

12

-2

12

1

0

1

45

6

44

37%

41%

BIOGEN INC.

$1,043

44

3

45

18

3

16

0

0

0

62

6

60

30%

38%

QUEST DIAGNOSTICS INC.

$3,628

-10

7

-13

66

-7

79

43

-3

38

51

-1

60

13%

12%

GUIDANT CORP.

$2,708

113

5

108

8

0

9

2

0

3

85

1

81

25%

23%

MEDTRONIC, INC.

$5,552

115

-9

121

14

-1

14

2

0

2

81

-7

85

33%

22%

CHIRON CORP.

$1,141

120

35

127

18

0

19

2

0

2

103

40

108

23%

23%

LABORATORY CORPORATION OF AMERICA HOLDINGS

$2,200

57

-9

64

10

0

10

33

-4

35

61

-9

68

14%

13%

DENTSPLY INTERNATIONAL INC.

$1,129

103

12

98

23

4

20

3

0

3

62

7

58

19%

17%

ST. JUDE MEDICAL, INC.

$1,347

128

-10

136

24

-1

26

2

0

2

87

-7

92

23%

21%

STRYKER CORP.

$2,602

87

-15

100

15

0

16

2

0

2

47

-8

55

18%

15%

QUINTILES TRANSNATIONAL CORP.

$1,620

84

7

77

12

-2

14

0

0

0

96

5

91

15%

8%

GENENTECH INC.

$2,082

91

4

111

6

-3

9

1

0

1

34

-2

45

23%

12%

BECKMAN COULTER INC.

$1,984

148

-1

150

23

4

23

3

0

3

104

0

107

14%

12%

APPLERA CORP.-APPLIED BIOSYSTEMS GROUP

$1,644

122

-21

133

0

0

0

5

1

4

89

-12

94

0%

0%

MONSANTO CO. NEW

$5,462

214

6

211

31

-4

33

2

0

2

154

-6

152

11%

9%

MEDICAL & BIOLOGICAL TECHNOLOGY Average

$2,544

99

2

102

19

-1

20

7

0

7

77

1

80

20%

18%



Email to a Colleague   Printer Friendly Version  

ad